8.94

1.21% -0.16

Avita Medical Inc (RCEL)

Overview News Price History Option Chain Financials Why RCEL Down? Discussions Forecast Stock Split

Avita Medical Inc stock is traded at $8.94, with a volume of 62,417. It is down -1.21% in the last 24 hours and up +1.35% over the past month. Avita is a single product company. Its RECELL system is an innovative burn treatment device which creates Spray-on Skin from a small skin sample within 30 minutes, thus avoiding or reducing the need for skin grafts. It's approved for the treatment of adult patients in the US with paediatric clinical trials and expanded indications in soft-tissue reconstruction and vitiligo underway. It is currently in roll-out across the approximately 136 US burn centers. Despite having product approval in Australia, Europe, Canada, and China, Avita is not actively marketing in those territories and focussing instead on the US region. However, it is expected to launch in Japan via distribution partner Cosmotec in second-half fiscal 2022. Avita is domiciled, and has its primary listing, in the US.

Previous Close:

$9.10

Open:

$9.11

24h Volume:

62,417

Relative Volume:

0.35

Market Cap:

$238.01M

Revenue:

$50.14M

Net Income/Loss:

$-35.38M

P/E Ratio:

-6.3857

EPS:

-1.4

Net Cash Flow:

$-39.46M

1W Performance:

-4.46%

1M Performance:

+1.35%

6M Performance:

+4.66%

1Y Performance:

-50.22%

1-Day Range:

$8.74

$9.64

1-Week Range:

$8.74

$9.82

52-Week Range:

$7.51

$18.26

Avita Medical Inc Stock (RCEL) Company Profile

Name

Avita Medical Inc

Sector

Healthcare (1188)

Industry

Medical Devices (159)

Phone

661-568-1317

Address

28159 AVENUE STANFORD, VALENCIA, CA

Employee

260

Twitter

@AvitaMedical

Next Earnings Date

2024-12-07

Latest SEC Filings

RCEL's Discussions on Twitter

Compare RCEL with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
RCEL Avita Medical Inc	8.935	238.01M	50.14M	-35.38M	-39.46M	-1.40
ABT Abbott Laboratories	140.56	241.69B	41.95B	13.40B	6.35B	7.65
BSX Boston Scientific Corp	105.36	153.75B	16.75B	1.85B	2.37B	1.25
SYK Stryker Corp	396.76	150.24B	22.60B	2.99B	3.49B	7.76
MDT Medtronic Plc	94.74	120.56B	33.20B	4.26B	5.47B	3.29
EW Edwards Lifesciences Corp	72.82	42.42B	5.72B	4.17B	490.10M	6.97

Avita Medical Inc Stock (RCEL) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Dec-24-24	Initiated	D. Boral Capital	Buy
Apr-11-24	Downgrade	BTIG Research	Buy → Neutral
Jun-27-23	Initiated	Cantor Fitzgerald	Overweight
Mar-02-21	Initiated	Piper Sandler	Overweight
Aug-27-20	Initiated	BofA Securities	Buy
Apr-21-20	Initiated	Oppenheimer	Outperform
Mar-03-20	Initiated	BTIG Research	Buy

View All

Avita Medical Inc Stock (RCEL) Latest News

Mar 01, 2025

How To Trade (RCEL) - Stock Traders Daily

Mar 01, 2025

Feb 27, 2025

Avita Medical LimitedADR to Host Earnings Call - ACCESS Newswire

Feb 27, 2025

Feb 26, 2025

AVITA Medical to Present at TD Cowen's 45ᵗʰ Annual Health Care Conference - The Manila Times

Feb 26, 2025

Can AVITA Medical's Conference Appearance Signal New Growth Opportunities in Wound Care? - StockTitan

Feb 26, 2025

Burns Pipeline 2024: Therapies, MOA Insights, and Key Clinical - openPR

Feb 26, 2025

Feb 24, 2025

D. Boral Capital Lowers AVITA Medical (NASDAQ:RCEL) Price Target to $22.00 - MarketBeat

Feb 24, 2025

Feb 23, 2025

AVITA Medical, Inc. (NASDAQ:RCEL) CFO David D. O'toole Buys 1,000 Shares - MarketBeat

Feb 23, 2025

Feb 22, 2025

Insider Buying: Robert Mcnamara Acquires 10,000 Shares of AVITA Medical Inc (RCEL) - GuruFocus.com

Feb 22, 2025

Feb 21, 2025

Insider Buying: AVITA Medical, Inc. (NASDAQ:RCEL) Director Acquires 10,000 Shares of Stock - MarketBeat

Feb 21, 2025

Wall Street Analysts Predict a 52.64% Upside in Avita Medical (RCEL): Here's What You Should Know - MSN

Feb 21, 2025

Avita medical CFO David O'Toole acquires $9,900 in common stock - Investing.com Australia

Feb 21, 2025

Avita Medical director Robert McNamara purchases $100,900 in stock By Investing.com - Investing.com South Africa

Feb 21, 2025

Avita medical CFO David O’Toole acquires $9,900 in common stock - Investing.com India

Feb 21, 2025

Feb 20, 2025

Avita Medical director Robert McNamara purchases $100,900 in stock - Investing.com India

Feb 20, 2025

Avita medical CFO David O'Toole acquires $9,900 in common stock By Investing.com - Investing.com South Africa

Feb 20, 2025